Text Version
RSS Feeds
Newsletter
Home Forum Photos Features Newsletter Archive Employment
About US Help Site Map
SEARCH   About US FAQ Site Map Site News
  SERVICES
  -Text Version
  -RSS Feeds
  -Newsletter
  -News Archive
  -Give us feedback
  -Voices of Readers
  -Online community
  -China Biz info
  What's new
Study: restless legs syndrome linked to genes
+ -
10:58, July 19, 2007

 Related News
 Search engine market: Google down a bit, MS up a bit
 Gene variant increases risk of blindness
 Gene identified for Crohn's disease in children
 Morocco, France sign cooperation agreement in genetic research
 China has 162 mln Internet users
 Comment  Tell A Friend
 Print Format  Save Article
Scientists have discovered certain genes linked to restless legs syndrome (RLS) -- an uncomfortable and sleep-robbing neurological disorder characterized by repeated movement of the legs, media reported Thursday.

The discovery, published simultaneously in the New England Journal of Medicine and in the online edition of Nature Genetics, suggested the twitching condition is biologically based and not an imaginary disorder.

The new studies are the first to identify specific genes responsible for restless legs syndrome symptoms.

Research in the New England Journal of Medicine looked at blood samples from more than 1,000 Icelanders and Americans, comparing the DNA of leg twitchers to the DNA of people without the symptom. They linked a common gene variation to night time leg-twitching.

A second study in Nature Genetics compared the DNA of 400 people with a family history of the syndrome with the DNA of 1,600 without. The study identified the same gene variation and two others in Germans and Canadians with restless legs syndrome.

"This discovery demonstrates the power of genetics not only for uncovering the biological causes of disease, but also for defining diseases such as RLS and establishing them as medical conditions," said Dr Kari Stefansson, a prominent Icelandic scientist and co-author of the New England Journal study.

Restless legs sydrome is commonly treated with two U.S. government-approved drugs including the heavily advertised Requip, made by GlaxoSmithKline PLC. Sales of Requip reached about 500 million U.S. dollars last year.

Source:Xinhua/agencies



  Your Message:   Most Commented:
Ambassador reviews Germany-China relations
President Hu vows to remain committed to "one country, two systems" principle
CPC full of vigor and vitality
Chinese leader urges college united front members to make more contribution
China's trade surplus expected to exceed 100 bln USD in first half

|About Peopledaily.com.cn | Advertise on site | Contact us | Site map | Job offer|
Copyright by People's Daily Online, All Rights Reserved

http://english.people.com.cn/90001/90781/6219274.pdf